Meihua International Medical Technologies Co., Ltd. (MHUAF)
OTCMKTS · Delayed Price · Currency is USD
7.13
+0.63 (9.69%)
At close: Aug 21, 2026
MHUAF Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6 | 1 | 11 | 35 | 198 | - | |
Market Cap Growth | -53.70% | -86.95% | -69.15% | -82.13% | - | - |
Enterprise Value | -0 | -3 | 4 | 25 | 170 | - |
Last Close Price | 7.13 | 2.05 | 34.51 | 148.00 | 828.00 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 0.40 | 0.21 | 1.01 | 3.05 | 31.75 | - |
PS Ratio | 0.10 | 0.02 | 0.11 | 0.37 | 1.92 | - |
PB Ratio | 0.03 | 0.01 | 0.07 | 0.24 | 1.43 | - |
P/TBV Ratio | 0.03 | 0.01 | 0.07 | 0.25 | 1.44 | - |
P/FCF Ratio | 11.01 | 2.57 | 0.75 | 32.42 | - | - |
P/OCF Ratio | 10.70 | 2.50 | 0.75 | 15.57 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | - | - | 0.04 | 0.26 | 1.64 | - |
EV/EBITDA Ratio | - | - | 0.28 | 1.67 | 10.52 | - |
EV/EBIT Ratio | - | - | 0.29 | 1.72 | 10.90 | - |
EV/FCF Ratio | - | - | 0.29 | 23.09 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
Debt / EBITDA Ratio | 1.02 | 1.02 | 0.53 | 0.48 | 0.42 | 0.19 |
Debt / FCF Ratio | 16.22 | 16.22 | 0.55 | 6.71 | - | - |
Net Debt / Equity Ratio | -0.03 | -0.03 | -0.05 | -0.06 | -0.14 | -0.03 |
Net Debt / EBITDA Ratio | -0.70 | -0.70 | -0.54 | -0.54 | -1.24 | -0.11 |
Net Debt / FCF Ratio | -11.13 | -11.13 | -0.55 | -7.53 | 1.68 | 3.28 |
Asset Turnover | 0.31 | 0.31 | 0.54 | 0.58 | 0.69 | 0.86 |
Inventory Turnover | 27.40 | 27.40 | 42.09 | 46.73 | 55.09 | 49.94 |
Quick Ratio | 6.19 | 6.19 | 4.18 | 5.16 | 4.87 | 3.26 |
Current Ratio | 8.41 | 8.41 | 5.26 | 5.27 | 5.60 | 3.34 |
Return on Equity (ROE) | 3.90% | 3.90% | 7.09% | 8.12% | 5.01% | 21.77% |
Return on Assets (ROA) | 2.63% | 2.63% | 5.00% | 5.47% | 6.47% | 13.51% |
Return on Invested Capital (ROIC) | 3.27% | 3.58% | 7.86% | 8.78% | 7.90% | 22.61% |
Return on Capital Employed (ROCE) | 4.40% | 4.40% | 9.00% | 10.00% | 11.20% | 24.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 111.17% | 475.60% | 99.21% | 32.81% | 3.15% | - |
FCF Yield | 9.09% | 38.87% | 132.69% | 3.08% | -5.98% | - |
Buyback Yield / Dilution | -37.38% | -37.38% | -14.34% | -2.26% | -17.05% | - |